PODD
Insulet Corporation
NASDAQ: PODD · HEALTHCARE · MEDICAL DEVICES
$172.14
+7.57% today
Updated 2026-04-30
Market cap
$11.08B
P/E ratio
46.12
P/S ratio
4.09x
EPS (TTM)
$3.47
Dividend yield
—
52W range
$158 – $355
Volume
1.1M
Insulet Corporation (PODD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
9.12%
Operating margin
18.70%
ROE
18.10%
ROA
9.43%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $3.66M | $-35.95M | -327.52% | -945.81% | -981.44% |
| 2007 | $13.37M | $-53.54M | -92.44% | -402.65% | -400.38% |
| 2008 | $36.06M | $-92.79M | -12.71% | -247.77% | -257.33% |
| 2009 | $66.03M | $-79.54M | 27.71% | -89.89% | -120.46% |
| 2010 | $96.97M | $-61.16M | 45.09% | -39.84% | -63.07% |
| 2011 | $152.25M | $-57.17M | 43.82% | -27.89% | -37.55% |
| 2012 | $211.37M | $-51.87M | 43.68% | -17.02% | -24.54% |
| 2013 | $247.08M | $-44.97M | 45.49% | -11.79% | -18.20% |
| 2014 | $288.72M | $-51.50M | 49.63% | -4.26% | -17.84% |
| 2015 | $263.89M | $-73.52M | 50.50% | -18.47% | -27.86% |
| 2016 | $366.99M | $-28.88M | 57.52% | -2.92% | -7.87% |
| 2017 | $463.77M | $-26.83M | 59.76% | -1.59% | -5.79% |
| 2018 | $563.82M | $3.29M | 65.65% | 4.86% | 0.58% |
| 2019 | $738.20M | $11.60M | 65.06% | 6.77% | 1.57% |
| 2020 | $904.40M | $6.80M | 64.39% | 5.69% | 0.75% |
| 2021 | $1.10B | $16.80M | 68.45% | 11.47% | 1.53% |
| 2022 | $1.31B | $4.60M | 61.72% | 2.88% | 0.35% |
| 2023 | $1.70B | $206.30M | 68.35% | 12.96% | 12.16% |
| 2024 | $2.07B | $418.30M | 69.79% | 14.91% | 20.19% |
| 2025 | $2.71B | $247.10M | 71.63% | 17.50% | 9.12% |